Blog

When iManage became an independent company, we spent hundreds of hours talking to our customers, getting their feedback about what was working and what wasn’t with our Work Product Management products.

Today, in response to increasing regulatory requirements, banks and other participants in the OTC derivatives market need to improve their ability to manage counterparty exposures and the corresponding collateral obligations.

When managing and maintaining our client’s Autonomy infrastructures, it’s often beneficial to thread the underlying scripts.